Recovery
Glepaglutide
Also called ZP1848
per administration
A human trial worked out how much to take and how often, so a dosing schedule is shown.
Work out your draw
These numbers are a starting point — change any of them.
- Concentration
- 3.33mg/mL
- Volume per draw
- 3mL
- Units to dial
- 300
- Doses per cartridge
- 1
This is 300 units, past the 60-unit dial. Splitting it across administrations, or using less water to raise the concentration, brings it back into range.
Dial range varies by pen; 1–60 units is the common configuration.
Vial label
Copy this into your label printer.
Published research contexts for Glepaglutide describe 10–10 mg per administration. Descriptive only, not a recommendation.
Roughly two days from limited reports; the figure is thin and estimates vary.
Dosing schedule
How Glepaglutide is commonly stepped up, for reference only.
These are commonly-discussed research protocols shared for educational reference. This is not medical advice and is not a substitute for guidance from a qualified professional.
| Phase | Amount | Frequency | Route |
|---|---|---|---|
| Reported doseThe long half-life supports weekly spacing; the EASE program ran 10 mg once or twice weekly. | 10 mg | Once or twice weekly | SubQ |
Modelled level — once a week
1× is the peak after a single dose.
- Steady-state peak
- 1.08× single dose
- Time to steady state
- 10.4days
- Administrations
- 1/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- Naimi RM et al., Lancet Gastroenterology & Hepatology 2019 (EASE-1)Subcutaneous glepaglutide (ZP1848) assessed for intestinal absorption in short-bowel syndrome; the later EASE program used 10 mg once or twice weekly.